We launched the one of the first patient-centric apps, making it easy for people to participate in digital clinical trials from the comfort of their homes. Our platform and app are backed by a team of clinical experts who offer support to participants every step of the way. This combination of tech and team boosts engagement. And when participants are engaged, you get better data.
Our Patient-centric features include:
Read more about our remote monitoring capabilities
"We are finishing our second study with ObvioHealth. It’s easy for me to pick up the phone … if there is a problem, I know that I have a partner. We will look together for solutions or different ways to get things done. I was particularly pleased with the proactivity from ObvioHealth's side. The project manager... was always thinking about solutions. I felt that ObvioHealth was building a relationship. They were not just saying I was a valuable client, they were acting upon it."
- Elizabeth Tarshish, LycoRed
"The team was very professional. We were looking for something very specific and they had the skills to go straight to it. They got to a finished product quite fast. I also appreciated their ability to flex. When we said 'don’t go in that direction,' they listened, stopped and changed. I also liked that they were able to bring in a regulatory partner – that they had access to a broader team. They brought different skill sets together."
- Principle Nutrition Scientist, Nutrition Company
"ObvioHealth worked very hard to incorporate and correlate all the inputs from 5 different devices into a single database along with the questionnaire which goes on their app. Integrating all of these pieces into a single database and making sure all they work together has been a massive undertaking and it’s worked out very well. When glitches arose, as would be expected in a novel situation such as this, the Obvio team was available to work through the problems and correct them for subsequent patient entry. I’d feel very comfortable recommending ObvioHealth."
- Dr. Terry Plasse, Medical Director, RedHill Biopharma
"You and your company have been outstanding in your responsiveness and professionalism and flexibility – even virtually!"
- Wayne Jonas, Executive Director
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
ObvioHealth is IQVIA Consumer Health’s preferred engine for virtual consumer scientific research, offering people-centric studies for better scientific claims, better insights and stronger brands.
Rapid growth in the Asia-Pacific (APAC) clinical research market has created strong opportunities for conducting decentralized clinical trials in the region, especially for North American sponsors looking for diverse and tech-savvy patient populations. A recent survey conducted by IQVIA shows participants are ready for the virtual transformation with 89% of patients at a West China Hospital citing decentralized trials as an acceptable option for research. That same survey found 98% of patients approve of the inclusion of electronic diaries, 96% approve of digital devices and 90% approve of telehealth visits as part of clinical trials.
Today, the English word “taboo” denotes behavior or topics that are culturally unacceptable or shameful. Numerous medical topics remain stigmatized—hindering clinical research and therapeutic development for health conditions that affect millions of patients. Decentralized trials (DCTs) offer an effective avenue for studying what are sometimes considered “taboo” therapeutic areas (those that involve highly personal or sensitive medical areas) while respecting participants’ preference for discretion and generating meaningful outcomes.
Novotech, a leading biotech specialist CRO in the Asia-Pacific region, and virtual research organization (VRO) partner ObvioHealth have been selected as finalists for the Clinical Partnership of the Year Citeline Award by Informa Pharma Intelligence. ObvioHealth is Novotech’s preferred provider for virtual clinical trials in APAC, while Novotech is ObvioHealth’s preferred CRO in the region for hybrid and virtual trials.
NEW YORK, September 30, 2021 - ObvioHealth, a global Virtual Research Organization (VRO), today announces the launch of a first-of-its kind clinical trial in Australia, using a combination of in-home data collection methods that will reduce and in some cases eliminate the need for follow-up visits to clinics.